Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study.
Vos
Eddie
E
Nehrlich
Herbert H
HH
D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D002784:Cholesterol / Q000172:deficiency; D002986:Clinical Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D003072:Cognition Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D015331:Cohort Studies; D003627:Data Interpretation, Statistical; D003704:Dementia / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006333:Heart Failure / Q000139:chemically induced / Q000378:metabolism / Q000401:mortality; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D015994:Incidence; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D018570:Risk Assessment
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018696:Neuroprotective Agents; D002784:Cholesterol